1. Application of PBPK modeling to evaluate pharmacokinetic drug-drug interactions during the development of new antimalarial combination therapies. Issue 1 (January 2019) Authors: Abla, Nada; Almond, Lisa; Dickins, Maurice; Gobeau, Nathalie; Charman, Susan A.; Rowland-Yeo, Karen; El Gaaloul, Myriam; Barter, Zoe; Moehrle, Joerg; Wesche, David; Burrows, Jeremy Journal: Drug metabolism and pharmacokinetics Issue: Volume 34:Issue 1(2019)Supplement Page Start: S68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. HOW DOES THE IN VIVO BILIARY ELIMINATION OF DRUGS CHANGE WITH AGE? EVIDENCE FROM CLINICAL DATA USING A SYSTEMS PHARMACOLOGY APPROACH. Issue 1 (14th December 2015) Authors: Johnson, Trevor; Rowland-Yeo, Karen; Jamei, Masoud; Rostami-Hodjegan, Amin Journal: Archives of disease in childhood Issue: Volume 101:Issue 1(2016) Page Start: e1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Modelling methods and case studies. Issue 1 (January 2017) Authors: Rowland-Yeo, Karen Journal: Drug metabolism and pharmacokinetics Issue: Volume 32:Issue 1(2017)Supplement Page Start: S4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Using human recombinant UDP-glucuronosyltransferase isoforms and a relative activity factor approach to model total body clearance of laropiprant (MK-0524) in humans. (29th April 2013) Authors: Gibson, Christopher R.; Lu, Ping; Maciolek, Cheri; Wudarski, Christen; Barter, Zoe; Rowland-Yeo, Karen; Stroh, Mark; Lai, Eseng; Nicoll-Griffith, Deborah A. Journal: Xenobiotica Issue: Volume 43:Number 12(2013:Dec.) Page Start: 1027 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗